Barrett Asset Management LLC bought a new position in Thermo Fisher Scientific Inc (NYSE:TMO) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 94,285 shares of the medical research company’s stock, valued at approximately $16,450,000.

Several other institutional investors also recently made changes to their positions in TMO. BlackRock Inc. boosted its holdings in shares of Thermo Fisher Scientific by 2,692.1% in the 1st quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after purchasing an additional 22,165,530 shares during the period. C WorldWide Group Holding A S boosted its holdings in shares of Thermo Fisher Scientific by 997.1% in the 1st quarter. C WorldWide Group Holding A S now owns 1,950,049 shares of the medical research company’s stock worth $299,527,000 after purchasing an additional 1,772,300 shares during the period. Harbour Capital Advisors LLC boosted its holdings in shares of Thermo Fisher Scientific by 18,197.5% in the 2nd quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock worth $6,884,000 after purchasing an additional 1,194,487 shares during the period. Veritas Asset Management LLP purchased a new position in shares of Thermo Fisher Scientific in the 1st quarter worth approximately $175,795,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Thermo Fisher Scientific by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after purchasing an additional 695,079 shares during the period. Hedge funds and other institutional investors own 83.52% of the company’s stock.

A number of equities analysts have recently commented on the company. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a report on Thursday, September 7th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Morgan Stanley restated an “overweight” rating and set a $220.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Finally, BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. One research analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and an average target price of $193.56.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 190.63 on Monday. The firm’s 50-day moving average price is $180.21 and its 200-day moving average price is $170.53. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $194.30. The company has a market capitalization of $74.37 billion, a price-to-earnings ratio of 33.21 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.03 earnings per share. Equities research analysts expect that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.45%.

COPYRIGHT VIOLATION NOTICE: “Barrett Asset Management LLC Takes Position in Thermo Fisher Scientific Inc (TMO)” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/18/barrett-asset-management-llc-takes-position-in-thermo-fisher-scientific-inc-tmo.html.

In other news, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the transaction, the vice president now owns 19,751 shares in the company, valued at $3,657,490.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director C Martin Harris sold 360 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the transaction, the director now owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The disclosure for this sale can be found here. Insiders sold 22,738 shares of company stock valued at $4,021,512 in the last quarter. Corporate insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.